SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001764013-24-000150
Filing Date
2024-08-13
Accepted
2024-08-13 16:12:19
Documents
13
Period of Report
2024-08-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K imvt-20240812.htm   iXBRL 8-K 37127
  Complete submission text file 0001764013-24-000150.txt   160492

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imvt-20240812.xsd EX-101.SCH 1898
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imvt-20240812_lab.xml EX-101.LAB 21629
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imvt-20240812_pre.xml EX-101.PRE 12506
15 EXTRACTED XBRL INSTANCE DOCUMENT imvt-20240812_htm.xml XML 2712
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38906 | Film No.: 241201580
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)